Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diabetic Retinopathy
|
213 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.060 | 0.833 | 6 | 2010 | 2017 | ||||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.040 | 0.750 | 4 | 2017 | 2018 | ||||||
Malignant tumor of cervix
|
245 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.020 | 1.000 | 2 | 2015 | 2015 | ||||||
Migraine Disorders
|
264 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
cervical cancer
|
268 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.020 | 1.000 | 2 | 2015 | 2015 | ||||||
Glycogen storage disease type II
|
269 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.020 | 2 | 2013 | 2016 | |||||||
Endometriosis
|
274 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.020 | 0.500 | 2 | 2013 | 2020 | ||||||
Bladder Neoplasm
|
281 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.030 | 0.667 | 3 | 2017 | 2019 | ||||||
Cervix carcinoma
|
283 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.020 | 1.000 | 2 | 2015 | 2015 | ||||||
Renal Cell Carcinoma
|
288 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.040 | 0.750 | 4 | 2017 | 2018 | ||||||
Carcinoma of bladder
|
309 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.030 | 0.667 | 3 | 2017 | 2019 | ||||||
Malignant neoplasm of urinary bladder
|
316 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.030 | 0.667 | 3 | 2017 | 2019 | ||||||
Neoplasm Metastasis
|
327 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Polycystic Ovary Syndrome
|
363 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Coronary Arteriosclerosis
|
440 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.030 | 1.000 | 3 | 2010 | 2018 | ||||||
Malignant neoplasm of stomach
|
615 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.020 | 1.000 | 2 | 2012 | 2018 | ||||||
Stomach Carcinoma
|
652 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Age related macular degeneration
|
663 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.020 | 2 | 2013 | 2016 | |||||||
Myocardial Infarction
|
680 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Psoriasis
|
705 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.020 | 0.500 | 2 | 2014 | 2017 | ||||||
Diabetes
|
710 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Diabetes Mellitus
|
824 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Multiple Myeloma
|
865 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Liver carcinoma
|
942 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.020 | 1.000 | 2 | 2017 | 2019 | ||||||
Primary malignant neoplasm of lung
|
981 | 0.570 | 0.680 | 6 | 43768652 | upstream gene variant | A/C;T | snv | 0.020 | 1.000 | 2 | 2014 | 2014 |